PNC Financial Services Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16
| Closed | -$654 | – | 4964 |
|
|
2024
Q2 | $654 | Buy |
16
+4
| +33% | +$164 | ﹤0.01% | 4494 |
|
|
2024
Q1 | $507 | Sell |
12
-6,488
| -100% | -$274K | ﹤0.01% | 4496 |
|
|
2023
Q4 | $276K | Sell |
6,500
-3,006
| -32% | -$127K | ﹤0.01% | 1920 |
|
|
2023
Q3 | $208K | Buy |
9,506
+3,866
| +69% | +$84.4K | ﹤0.01% | 2094 |
|
|
2023
Q2 | $179K | Buy |
+5,640
| New | +$179K | ﹤0.01% | 2280 |
|